(Ferguson-Smith type), genetically predisposed KA (such as in xeroderma pigmentosum, or Muir-Torre syndrome), or sporadic multiple eruptive KA (Grzybowski type) have been described. Generalized eruptive KA of Grzybowski (GEKA) is a rare condition (around 40 reported cases). The pathophysiology is still unclear. Human papillomavirus (HPV) has been detected in sporadic KA but the presence of HPV39 has never been reported, to our knowledge, in GEKA. Case Report: GEKA in an 80-year-old woman was successfully treated with acitretin (0.5 mg/ kg/day) combined with surgical removal of the largest lesions. Treatment was well tolerated and led to decreased pruritus and tumor regression within 6 months. The presence of HPV39 was detected in a lesion by polymerase chain reaction and Sanger sequencing. No genetic alteration was found, in particular in the genes usually altered in squamous cell carcinoma (including NOTCH1, NOTCH2, CDKN2A, TP53). Conclusion: We report a case of GEKA associated with the presence of HPV39 and the successful use of acitretin combined with surgical removal of the larger lesions. 
INTRODUCTION
Keratoacanthomas (KA) are common cutaneous skin tumors originating from the hair follicles [1] . The lesions present typically as crateriform tumors and are more frequent in men [2] . Unlike squamous cell carcinoma (SCC), KA has a spontaneously regressive, benign evolution [3] . Solitary KA is the most common form but there are rare cases of familial multiple KA (Ferguson-Smith type [4] ), genetically predisposed KA (such as in xeroderma pigmentosum [5] , or Muir-Torre syndrome [6] ), or sporadic multiple eruptive KA (Grzybowski type). Generalized eruptive KA of Grzybowski (GEKA) was first described in 1950 [7] . About 40 cases have been reported. Nofal et al. [8] proposed the following consistent diagnostic criteria: onset in adulthood (usually in the fifth to seventh decade of life); generalized eruption of hundreds to thousands of well-demarcated papules, some with a keratotic center; progressive course; severe and persistent pruritus; histopathological examination consistent with KA; and lack of family history of multiple KA. The presence of a masked face (''mask of Zorro'' sign), mucosal lesions, ectropion, and crateriform nodules have been suggested as variable criteria [8] .
The lesions are typically widespread but predominate in sun-exposed areas [9] . The etiology of eruptive KA remains unknown. Radiation [10] , immunosuppression [11] , skin trauma [12] , and treatments with BRAF [13] and Sonic Hedgehog pathway inhibitors have been reported as potential risk factors. A viral trigger has been proposed. Human papillomavirus (HPV) has been detected in sporadic KA [14] [15] [16] but the presence of HPV39 has never been reported, to our knowledge, in GEKA.
CASE REPORT
We present the case of a woman in her 80s with a GEKA who presented with a 6-month history of extremely pruritic lesions. Informed consent was obtained from the individual participant included in the study. She reported the sudden onset of hundreds of 1-to 3-mm scaly papules located on her legs, arms, and trunk, without any identified trigger. A few days after an emotional shock, some of the lesions had evolved into large crateriform tumors (Fig. 1a-c) . She had no familial medical history but had a personal history of hypertension, depression, and sun exposure. She had been previously treated with antihistamines, topical corticosteroids, and 20 sessions of phototherapy without success. The phototherapy was initially prescribed for suspected prurigo but was followed by a worsening of the skin lesions.
There were numerous follicular papules with keratotic centers, erythematous nodules on the legs, arms, and trunk, and ten 1.5-to 3.5-cmdiameter crateriform tumors of the limbs. The physical examination did not show mucosal involvement, sclerotic skin changes, or lymphadenopathy. There was no deterioration of her general condition. A full-body computed tomography (CT) scan was within normal limits. Blood work revealed negative results for her human immunodeficiency virus serology and a normal complete blood cell count. A biopsy specimen was obtained from one of the skin tumors (Fig. 2a, b) . Histopathological examination of the specimen obtained from the patient's leg revealed a crater-shaped squamous proliferation connected to the epidermis and penetrating the dermis, with a central keratin plug (Fig. 2a) . The keratinocytes were large and surrounded by a moderately abundant inflammatory infiltrate (Fig. 2b) .
Molecular detection of HPV was performed on the skin sample by polymerase chain reaction using degenerate primers, followed by Sanger sequencing [17] . One a-HPV was detected: HPV type 39.
No genetic alteration was found in the genes usually altered in SCC (including NOTCH1, NOTCH2, CDKN2A, TP53) [18] on a lesional skin biopsy using a homemade next-generation sequencing panel covering skin carcinoma genes (90 genes). The patient was not screened for mismatch repair gene alterations (MLH1, MSH2, and MSH6) because she had not developed any other neoplasm associated with Muir-Torre syndrome. In particular, there was no history of sebaceous tumors.
The largest skin lesions were surgically removed and oral acitretin was started (0.5 mg/ kg/day), allowing a decrease in pruritus and the disappearance of numerous lesions (Fig. 1d-f) . No new KA appeared under acitretin. She has been successfully treated with acitretin for 1 year.
DISCUSSION
Here, we report a new case of GEKA associated with the presence of HPV39. GEKA is a rare skin disease for which the pathophysiology remains Histopathological examination of a KA is necessary to rule out the differential diagnoses of crateriform papules or nodules, including SCC, amelanotic melanoma, CD30
? anaplastic lymphoma, giant molluscum contagiosum, and hypertrophic lichen planus. Distinguishing KA and SCC can be challenging, particularly on a limited skin biopsy. KA are exo-endophytic lesions with an invaginating keratin-filled crater with a symmetrical epidermal proliferation at the sides and bottom of the lesion. Nuclear atypia and mitotic activity are rare, unlike in SCC [17] . Surgical excision with margins of 5 mm is the rule for solitary KA. Treatment of GEKA has not been uniformly satisfactory. Acitretin (0.5-1 mg/kg) is usually proposed as firstline treatment [19] [20] [21] . Methotrexate [22] [23] [24] , topical 5-fluorouracil [21] , cyclophosphamide [25, 26] , and erlotinib [27, 28] are other reported therapeutic options. Here, acitretin combined with a surgical procedure was used successfully.
More than 200 different types of HPV have been identified [29] . HPV are classified into five genera: a, b, c, l, m. The role of a-papillomavirus in the oncogenesis of SCC is well known [30] . Epidemiologically, the mucocutaneous HPV types can be subdivided on the basis of whether they are associated with benign or malignant lesions [31] . Low-risk HPV (HPV6 and HPV11) have been detected in two cases of sporadic KA [15, 16] but the presence of high-risk HPV has never been reported, to our knowledge, either in KA or GEKA. HPV39 belongs to the oncogenic, high-risk a-papillomavirus types which are associated with a high risk of neoplasia (cervical, anal, vaginal, vulvar, penile, and oropharyngeal cancers and associated precursor lesions).
Interestingly, here, no genetic alteration was found in the genes usually affected in skin SCC, which suggests that KA and SCC have distinct pathogenetic mechanisms.
One of the limitations of our report is that the presence of HPV has only been studied in lesional skin and thus its presence may be coincidental. However, HPV39 is rarely found in healthy skin [32] . More studies are needed to explore the potential oncogenic role of HPV39 in KA. CONCLUSIONS GEKA is a rare condition for which the pathophysiology is still unclear. To our knowledge, this is the first documented case of GEKA associated with HPV39. The potentially central role of this oncogenic a-papillomavirus in the pathophysiology of GEKA warrants further investigation. Interestingly, no genetic alteration was found in our patient's tumor, which may explain its benign course.
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